Pleuropulmonary blastoma-like peritoneal sarcoma: a newly described malignancy associated with biallelic DICER1 pathogenic variation.


Journal

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
ISSN: 1530-0285
Titre abrégé: Mod Pathol
Pays: United States
ID NLM: 8806605

Informations de publication

Date de publication:
10 2020
Historique:
received: 19 02 2020
accepted: 16 04 2020
revised: 16 04 2020
pubmed: 18 5 2020
medline: 3 8 2021
entrez: 17 5 2020
Statut: ppublish

Résumé

Since the original description of pathogenic germline DICER1 variation underlying pleuropulmonary blastoma (PPB), the spectrum of extrapulmonary neoplasms known to be associated with DICER1 has continued to expand and now includes tumors of the ovary, thyroid, kidney, eye, and brain among other sites. This report documents our experience with another manifestation: a primitive sarcoma that resembles PPB and DICER1-associated sarcoma of the kidney. These tumors are distinguished by their unusual location in the peritoneal cavity, associated with visceral and/or parietal mesothelium. A total of seven cases were identified through pathology review in children presenting at a median age of 13 years (range 3-14 years). Primary sites of origin included the fallopian tube (four cases), serosal surface of the colon (one case), and pelvic sidewall (two cases). One case had pathologic features of type I PPB, another type Ir (regressed) PPB, and the remaining five had features of type II or III PPB with a mixed primitive sarcomatous pattern with or without cystic elements. All had a pathogenic DICER1 variation identified in germline and/or tumor DNA. PPB-like peritoneal tumors represent a newly described manifestation of DICER1 pathogenic variation whose pathologic features are also recapitulated in DICER1-related renal sarcoma, cervical embryonal rhabdomyosarcoma, and some Sertoli-Leydig cell tumors with heterologous elements. Tumors arising from the fallopian tube or elsewhere in the abdomen/pelvis, especially those with heterogeneous rhabdomyosarcomatous and/or cartilaginous differentiation, should prompt consideration of germline and tumor DICER1 testing.

Identifiants

pubmed: 32415267
doi: 10.1038/s41379-020-0558-4
pii: S0893-3952(22)00462-8
pmc: PMC7529703
mid: NIHMS1586293
doi:

Substances chimiques

DICER1 protein, human EC 3.1.26.3
Ribonuclease III EC 3.1.26.3
DEAD-box RNA Helicases EC 3.6.4.13

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1922-1929

Subventions

Organisme : NCI NIH HHS
ID : L40 CA171135
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA143167
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA244940
Pays : United States
Organisme : NCI NIH HHS
ID : R37 CA244940
Pays : United States

Références

Hill DA, Ivanovich J, Priest JR, Gurnett CA, Dehner LP, Desruisseau D, et al. DICER1 mutations in familial pleuropulmonary blastoma. Science. 2009;325:965.
doi: 10.1126/science.1174334
Pugh TJ, Yu W, Yang J, Ambrogio L, Carter SL, Kiezun A, et al. Progressive biallelic loss of TP53 is associated with progression of pleuropulmonary blastoma initiated by germline loss and somatic mutation of DICER1 [abstract]. Cancer Res. 2013;73:3806.
Brenneman M, Field A, Yang J, Williams G, Doros L, Rossi C, et al. Temporal order of RNase IIIb and loss-of-function mutations during development determines phenotype in pleuropulmonary blastoma/DICER1 syndrome: a unique variant of the two-hit tumor suppression model. F1000Res. 2015;4:214.
doi: 10.12688/f1000research.6746.1
Messinger YH, Stewart DR, Priest JR, Williams GM, Harris AK, Schultz KA, et al. Pleuropulmonary blastoma: a report on 350 central pathology-confirmed pleuropulmonary blastoma cases by the International Pleuropulmonary Blastoma Registry. Cancer. 2015;121:276–85.
doi: 10.1002/cncr.29032
Nakano Y, Hasegawa D, Stewart DR, Schultz KAP, Harris AK, Hirato J, et al. Presacral malignant teratoid neoplasm in association with pathogenic DICER1 variation. Mod Pathol. 2019;32:1744–50.
doi: 10.1038/s41379-019-0319-4
Doros LA, Rossi CT, Yang J, Field A, Williams GM, Messinger Y, et al. DICER1 mutations in childhood cystic nephroma and its relationship to DICER1-renal sarcoma. Mod Pathol. 2014;27:1267–80.
doi: 10.1038/modpathol.2013.242
Schultz KA, Harris A, Messinger Y, Sencer S, Baldinger S, Dehner LP, et al. Ovarian tumors related to intronic mutations in DICER1: a report from the international ovarian and testicular stromal tumor registry. Fam Cancer. 2016;15:105–10.
doi: 10.1007/s10689-015-9831-y
Rutter MM, Jha P, Schultz KA, Sheil A, Harris AK, Bauer AJ, et al. DICER1 mutations and differentiated thyroid carcinoma: evidence of a direct association. J Clin Endocrinol Metab. 2016;101:1–5.
doi: 10.1210/jc.2015-2169
de Kock L, Priest JR, Foulkes WD, Alexandrescu S. An update on the central nervous system manifestations of DICER1 syndrome. Acta Neuropathol. 2020;139:689–701.
doi: 10.1007/s00401-019-01997-y
Stewart DR, Best AF, Williams GM, Harney LA, Carr AG, Harris AK, et al. Neoplasm risk among individuals with a pathogenic germline variant in DICER1. J Clin Oncol. 2019;37:668–76.
doi: 10.1200/JCO.2018.78.4678
Schultz KA, Pacheco MC, Yang J, Williams GM, Messinger Y, Hill DA, et al. Ovarian sex cord-stromal tumors, pleuropulmonary blastoma and DICER1 mutations: a report from the International Pleuropulmonary Blastoma Registry. Gynecol Oncol. 2011;122:246–50.
doi: 10.1016/j.ygyno.2011.03.024
Doros L, Schultz KA, Stewart DR, Bauer AJ, Williams G, Rossi CT, et al. DICER1-related disorders. In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, et al., editors. GeneReviews(R). Seattle, WA: University of Washington, Seattle University of Washington; 2015.
Schultz KAP, Harris AK, Finch M, Dehner LP, Brown JB, Gershenson DM, et al. DICER1-related Sertoli-Leydig cell tumor and gynandroblastoma: clinical and genetic findings from the International Ovarian and Testicular Stromal Tumor Registry. Gynecol Oncol. 2017;147:521–7.
doi: 10.1016/j.ygyno.2017.09.034
Priest JR, Williams GM, Manera R, Jenkinson H, Brundler MA, Davis S, et al. Ciliary body medulloepithelioma: four cases associated with pleuropulmonary blastoma-a report from the International Pleuropulmonary Blastoma Registry. Br J Ophthalmol. 2011;95:1001–5.
doi: 10.1136/bjo.2010.189779
Stewart DR, Messinger Y, Williams GM, Yang J, Field A, Schultz KA, et al. Nasal chondromesenchymal hamartomas arise secondary to germline and somatic mutations of DICER1 in the pleuropulmonary blastoma tumor predisposition disorder. Hum Genet. 2014;133:1443–50.
doi: 10.1007/s00439-014-1474-9
Dehner LP, Messinger YH, Schultz KA, Williams GM, Wikenheiser-Brokamp K, Hill DA. Pleuropulmonary blastoma: evolution of an entity as an entry into a familial tumor predisposition syndrome. Pediatr Dev Pathol. 2015;18:504–11.
doi: 10.2350/15-10-1732-OA.1
Apellaniz-Ruiz M, Segni M, Kettwig M, Glüer S, Pelletier D, Nguyen VH, et al. Mesenchymal hamartoma of the liver and DICER1 syndrome. N Engl J Med. 2019;380:1834–42.
doi: 10.1056/NEJMoa1812169
Vargas SO, Perez-Atayde AR. Mesenchymal hamartoma of the liver and DICER1 syndrome. N Engl J Med. 2019;381:586–7.
doi: 10.1056/NEJMc1907523
Chernock RD, Rivera B, Borrelli N, Hill DA, Fahiminiya S, Shah T, et al. Poorly differentiated thyroid carcinoma of childhood and adolescence: a distinct entity characterized by DICER1 mutations. Mod Pathol. 2020;10.1038/s41379-020-0458-7. https://doi.org/10.1038/s41379-020-0458-7 . [Epub ahead of print, 14 Jan 2020].
Warren M, Hiemenz MC, Schmidt R, Shows J, Cotter J, Toll S, et al. Expanding the spectrum of dicer1-associated sarcomas. Mod Pathol. 2020;33:164–74.
doi: 10.1038/s41379-019-0366-x
Witt RG, Baldini EH, Raut CP. Screening populations at high risk for soft tissue sarcoma and surveillance following soft tissue sarcoma resection. J Surg Oncol. 2019;120:882–90.
doi: 10.1002/jso.25676
Schultz KA, Harris A, Williams GM, Baldinger S, Doros L, Valusek P, et al. Judicious DICER1 testing and surveillance imaging facilitates early diagnosis and cure of pleuropulmonary blastoma. Pediatr Blood Cancer. 2014;61:1695–7.
doi: 10.1002/pbc.25092
Schultz KA, Yang J, Doros L, Williams GM, Harris A, Stewart DR, et al. DICER1-pleuropulmonary blastoma familial tumor predisposition syndrome: a unique constellation of neoplastic conditions. Pathol Case Rev. 2014;19:90–100.
doi: 10.1097/PCR.0000000000000027
Priest JR, Watterson J, Strong L, Huff V, Woods WG, Byrd RL, et al. Pleuropulmonary blastoma: a marker for familial disease. J Pediatr. 1996;128:220–4.
doi: 10.1016/S0022-3476(96)70393-1
Boman F, Hill DA, Williams GM, Chauvenet A, Fournet JC, Soglio DB, et al. Familial association of pleuropulmonary blastoma with cystic nephroma and other renal tumors: a report from the International Pleuropulmonary Blastoma Registry. J Pediatr. 2006;149:850–4.
doi: 10.1016/j.jpeds.2006.08.068
Dehner LP, Schultz KA, Hill DA. Pleuropulmonary blastoma: more than a lung neoplasm of childhood. Mo Med. 2019;116:206–10.
pubmed: 31527943 pmcid: 6690274
Yin Y, Castro AM, Hoekstra M, Yan TJ, Kanakamedala AC, Dehner LP, et al. Fibroblast growth factor 9 regulation by MicroRNAs controls lung development and links DICER1 loss to the pathogenesis of pleuropulmonary blastoma. PLoS Genet. 2015;11:e1005242.
doi: 10.1371/journal.pgen.1005242
Colvin JS, White AC, Pratt SJ, Ornitz DM. Lung hypoplasia and neonatal death in Fgf9-null mice identify this gene as an essential regulator of lung mesenchyme. Development. 2001;128:2095–106.
pubmed: 11493531
Bean GR, Anderson J, Sangoi AR, Krings G, Garg K. DICER1 mutations are frequent in müllerian adenosarcomas and are independent of rhabdomyosarcomatous differentiation. Mod Pathol. 2019;32:280–9.
doi: 10.1038/s41379-018-0132-5
de Kock L, Yoon JY, Apellaniz-Ruiz M, Pelletier D, McCluggage WG, Stewart CJR, et al. Significantly greater prevalence of DICER1 alterations in uterine embryonal rhabdomyosarcoma compared to adenosarcoma. Mod Pathol. 2020;10.1038/s41379-019-0436-0. https://doi.org/10.1038/s41379-019-0436-0 . [Epub ahead of print, 3 Jan 2020].
Schultz KAP, Williams GM, Kamihara J, Stewart DR, Harris AK, Bauer AJ, et al. DICER1 and associated conditions: identification of at-risk individuals and recommended surveillance strategies. Clin Cancer Res. 2018;24:2251–61.
doi: 10.1158/1078-0432.CCR-17-3089
van Engelen K, Villani A, Wasserman JD, Aronoff L, Greer MC, Tijerin Bueno M, et al. DICER1 syndrome: approach to testing and management at a large pediatric tertiary care center. Pediatr Blood Cancer. 2018;65.

Auteurs

Kris Ann P Schultz (KAP)

International Pleuropulmonary Blastoma/DICER1 Registry, Children's Minnesota, Minneapolis, MN, USA. KrisAnn.Schultz@childrensmn.org.
International Ovarian and Testicular Stromal Tumor Registry, Children's Minnesota, Minneapolis, MN, USA. KrisAnn.Schultz@childrensmn.org.
Cancer and Blood Disorders, Children's Minnesota, Minneapolis, MN, USA. KrisAnn.Schultz@childrensmn.org.

Alexander Nelson (A)

International Pleuropulmonary Blastoma/DICER1 Registry, Children's Minnesota, Minneapolis, MN, USA.
International Ovarian and Testicular Stromal Tumor Registry, Children's Minnesota, Minneapolis, MN, USA.
Cancer and Blood Disorders, Children's Minnesota, Minneapolis, MN, USA.

Anne K Harris (AK)

International Pleuropulmonary Blastoma/DICER1 Registry, Children's Minnesota, Minneapolis, MN, USA.
International Ovarian and Testicular Stromal Tumor Registry, Children's Minnesota, Minneapolis, MN, USA.
Cancer and Blood Disorders, Children's Minnesota, Minneapolis, MN, USA.

Mike Finch (M)

Children's Research Institute, Children's Minnesota, Minneapolis, MN, USA.

Amanda Field (A)

ResourcePath, Sterling, VA, USA.

Jason A Jarzembowski (JA)

Department of Pathology, Medical College of Wisconsin and Children's Wisconsin, Milwaukee, WI, USA.

Mercedes Wilhelm (M)

International Pleuropulmonary Blastoma/DICER1 Registry, Children's Minnesota, Minneapolis, MN, USA.
International Ovarian and Testicular Stromal Tumor Registry, Children's Minnesota, Minneapolis, MN, USA.
Cancer and Blood Disorders, Children's Minnesota, Minneapolis, MN, USA.

William Mize (W)

Department of Radiology, Children's Minnesota, Minneapolis, MN, USA.

Portia Kreiger (P)

Department of Anatomical Pathology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Katrina Conard (K)

Department of Clinical & Anatomic Pathology, Nemours/Alfred I. duPont Hospital for Children, Wilmington, DE, USA.

Andrew Walter (A)

Department of Oncology, Nemours/Alfred I. duPont Hospital for Children, Wilmington, DE, USA.

Thomas Olson (T)

Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA, USA.

Sarah Mitchell (S)

Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA, USA.

Daniel V Runco (DV)

Division of Hematology/Oncology, Riley Hospital for Children at Indiana University Health/Indiana University School of Medicine, Indianapolis, IN, USA.

Allison Bechtel (A)

Division of Hematology/Oncology, Nemours Children's Specialty Care, Jacksonville, FL, USA.

Darren Klawinski (D)

Division of Hematology/Oncology, Nemours Children's Specialty Care, Jacksonville, FL, USA.

Scott Bradfield (S)

Division of Hematology/Oncology, Nemours Children's Specialty Care, Jacksonville, FL, USA.

Katie Gettinger (K)

Department of Oncology, Washington University Medical Center, St. Louis, MO, USA.

Douglas R Stewart (DR)

Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.

Yoav Messinger (Y)

International Pleuropulmonary Blastoma/DICER1 Registry, Children's Minnesota, Minneapolis, MN, USA.
International Ovarian and Testicular Stromal Tumor Registry, Children's Minnesota, Minneapolis, MN, USA.
Cancer and Blood Disorders, Children's Minnesota, Minneapolis, MN, USA.

Louis P Dehner (LP)

International Pleuropulmonary Blastoma/DICER1 Registry, Children's Minnesota, Minneapolis, MN, USA.
International Ovarian and Testicular Stromal Tumor Registry, Children's Minnesota, Minneapolis, MN, USA.
Lauren V. Ackerman Laboratory of Surgical Pathology, Department of Pathology and Immunology, Washington University Medical Center, St. Louis, MO, USA.

D Ashley Hill (D)

International Pleuropulmonary Blastoma/DICER1 Registry, Children's Minnesota, Minneapolis, MN, USA.
International Ovarian and Testicular Stromal Tumor Registry, Children's Minnesota, Minneapolis, MN, USA.
ResourcePath, Sterling, VA, USA.
Department of Pathology and Laboratory Medicine, Children's National Medical Center, Washington, DC, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH